Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 34.06M 38.94M 31.41M 29.06M 55.16M 3.72B 56.09M 376M 147M 1.83B 146M 143M 6.32B | P/E 2026 * |
-5.52x | P/E 2027 * | 38.7x |
|---|---|---|---|---|---|
| Enterprise Value | 34.06M 38.94M 31.41M 29.06M 55.16M 3.72B 56.09M 376M 147M 1.83B 146M 143M 6.32B | EV / Sales 2026 * |
11.4x | EV / Sales 2027 * | 3.41x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 38.43M | |
| -0.87% | -3.53% | +49.31% | +13.67% | 311B | |
| +0.32% | -5.36% | +25.43% | -4.29% | 68.98B | |
| -1.01% | -0.97% | +39.06% | +110.83% | 9.53B | |
| -0.21% | +4.27% | +6.96% | +1.89% | 8.62B | |
| -2.31% | -7.50% | -13.48% | +6.37% | 4.26B | |
| +4.55% | -4.61% | +15.19% | +24.63% | 3.83B | |
| -2.46% | -4.40% | -36.65% | +24.81% | 3.41B | |
| -21.97% | +0.12% | +47.26% | +61.28% | 2.93B | |
| +0.28% | -6.94% | +9.56% | -24.42% | 2.08B | |
| Average | -1.54% | -1.68% | +15.85% | +23.86% | 46.09B | |
| Weighted average by Cap. | -0.68% | -0.40% | +42.35% | +12.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.43M 2.77M 2.56M 4.86M 327M 4.94M 33.13M 12.99M 161M 12.87M 12.6M 557M | 10M 11.43M 9.22M 8.53M 16.19M 1.09B 16.47M 110M 43.29M 536M 42.91M 41.99M 1.86B |
| Net income | -6M -6.86M -5.53M -5.12M -9.72M -655M -9.88M -66.26M -25.97M -321M -25.75M -25.19M -1.11B | 1M 1.14M 922K 853K 1.62M 109M 1.65M 11.04M 4.33M 53.58M 4.29M 4.2M 186M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
